• View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

  • Nov 20 2023
  • Length: 23 mins
  • Podcast

View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up By cover art

View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Listen for free

View show details

  • Summary

  • What's hot at #AHA23? Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023. They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research. Trials Covered include: 00:20 - DAPA-MI: Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack 06:30 - ORBITA-2: Percutaneous Coronary Intervention for Stable Angina: A Randomised, Placebo-Controlled Trial 12:39 - A Sub-Analysis of the Prospective ECLS-Shock Trial 16:13 - ARTESiA: Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation 10:02 - SELECT: Semaglutide and Cardiovascular Outcomes in Patients With Overweight or Obesity Who Do Not Have Diabetes We value your opinion! Share your feedback by commenting on this page or sending us an email at info@radcliffe-group.com.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Show more Show less

What listeners say about View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available